The clinical trial was always Ph1b (I'm not sure why it's shown as Ph2a in the first place or what you mean by Ph1a????). I'm not sure why the Primary completion was shown as March this year as well so March 2026 isn't that a surprise as IMU did mention they are targeting registration clinical trial end of 2025 but the final observation of 2 years is a surprise after the end of Primary completion, IMU will still be releasing clinical updates during the Primary completion as expected end of this year. Is the 2 years for the final observation part of regional clinical trial if approved???
The clinical trial was always Ph1b (I'm not sure why it's shown...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1082545 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 603058 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |